Boehringer Ingelheim Innovation Prize Launch EventMarch 03, 2021
Time: 11 AM - 12 PM
Join LabCentral, Boehringer Ingelheim, and two company leaders for a panel discussion about the Innovation Prize experience.
The innovation power of young life-science companies and bio-entrepreneurs is vital for the discovery of the next generation of breakthrough medicines. Boehringer Ingelheim's Innovation Prize recognizes the challenge and dedication it takes to start a new company by supporting the innovation process and celebrating life-science entrepreneurs.
As a Gold Sponsor of LabCentral, Boehringer Ingelheim selects one innovative life sciences start-up company per year for a “Golden Ticket,” which covers the cost of one 6-foot lab bench and one resident scientist fee at LabCentral’s Kendall Square facility for one year.
LabCentral provides fully equipped, permitted and supported lab space for biomedical research, plus programming and unmatched networking opportunities to help start-ups advance their science and build their companies.
Innovation Prize winners Joanna Stanika, CEO of Axonis, and John Reilly, CEO of Apic Bio, will take you through their journey to BI and their experience at LabCentral. Boehringer Ingelheim team members Cyrille Kuhn and Andrew Hutchinson will share guidance and best practices for applicants.
You'll walk away from the event with information about the application and selection process, key reasons to partner with Boehringer Ingelheim, and the benefits to residency at LabCentral.
Johannes Fruehauf, Co-Founder and President of LabCentral
Joanna Stanika, CEO of Axonis
John Reilly, CEO of Apic Bio
Cyrille Kuhn, Head of Research Beyond Borders North America at Boehringer Ingelheim
Andrew Hutchinson, Head of Immunology Business Development & Licensing at Boehringer Ingelheim
Scott DeWire, Head of Business Development and Licensing, US at Boehringer Ingelheim